Pfizer and BioNTech have asked U.S. regulators to approve emergency use of their Covid-19 vaccine for children ages 5 to 11. The move comes at a time when children are heading back to school and ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (both Original and Omicron BA.4/BA.5) is already FDA-authorized under an EUA for use in individuals 12 years old and above as a single booster dose ...
Pfizer and BioNTech's Covid-19 vaccine for kids should be the topic of discussion when the FDA's vaccine advisory committee meets Tuesday. The companies said that the vaccine was effective at ...
The federal Centers for Disease Control and Prevention has added the Covid-19 vaccine to the recommended immunization schedule for children and adolescents. The Advisory Committee on Immunization ...
(The Hill) — The Food and Drug Administration (FDA) on Tuesday announced it was simplifying its recommended COVID-19 vaccine schedule, stating a single dose of the bivalent vaccine specific to ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
“This decision comes at a time when Covid-19 cases are once again climbing,” Bourla said The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed ...
T he COVID vaccine may be linked to a small increase in stroke risk when given with a high-dose flu shot, primarily in ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
Last fall, U.S. health officials authorized new COVID-19 booster shots designed to target the original strain of the coronavirus and some of the Omicron subvariants that were circulating around ...
Moderna Says Its COVID Vaccine Works in Kids Under 6The company plans to seek FDA authorization in the coming weeks, though the shot’s modest efficacy against symptomatic COVID-19 could cause ...
(Reuters) -The U.S. health regulator on Monday proposed the use of one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it ...